title: Uroporphyria induced by 5-aminolaevulinic acid alone in Ahrd SWR mice.
abstract: In mice, depression of hepatic uroporphyrinogen decarboxylase (UROD) leading to porphyrin accumulation (uroporphyria) occurs with chlorinated ligands of the aryl hydrocarbon (AH) receptor especially after iron overload. However, in the absence of chlorinated ligands, iron itself will eventually cause uroporphyria, but this response is not associated with the Ahr genotype. These effects are potentiated by administration of the haem precursor 5-aminolaevulinate (ALA). The aim of this study was to investigate the effects of ALA alone. Prolonged administration of 2 mg ALA/mL in the drinking water to SWR mice also led to decarboxylase insufficiency (11% of control) and uroporphyria by 8 weeks, whereas DBA/2 mice did not show reduced enzyme activity. Both strains are considered AH nonresponsive and analysis of the Ahr gene using restriction fragment length polymorphism was consistent with SWR, like DBA/2, possessing the Ahrd allele. Exposure of isolated hepatocytes to ALA (150-500 microM) for up to 48 hr showed a significant accumulation of both uroporphyrin and coproporphyrin in the medium, which for uroporphyrin particularly was significantly greater with SWR than with DBA/2 cells. Basal in vivo CYP1A2 activity, measured as microsomal methoxyresorufin dealkylation, was significantly greater in SWR than in DBA/2 mice (1.3-fold), but it was unclear whether this was sufficient to explain the marked difference in sensitivities of the two strains. Despite SWR mice being AH nonresponsive, uroporphyria and decarboxylase depression after an initial iron overload and ALA for 3 weeks were greatly potentiated by a single dose (100 mg/kg) of hexachlorobenzene (a weak AH ligand). The results demonstrate that there is a genetic difference in mice independent of the Ahr genotype and response to iron, which influences the susceptibility to ALA-induced uroporphyria. Thus chemicals, iron and ALA can act independently, but also together, to cause porphyria in susceptible individuals.
authors.affiliation: MRC Toxicology Unit, University of Leicester, U.K.
authors.forename: D
authors.initials: D
authors.lastname: Constantin
authors.forename: J E
authors.initials: JE
authors.lastname: Francis
authors.forename: R A
authors.initials: RA
authors.lastname: Akhtar
authors.forename: B
authors.initials: B
authors.lastname: Clothier
authors.forename: A G
authors.initials: AG
authors.lastname: Smith
mesh_terms: D000622:Aminolevulinic Acid / Q000633:toxicity*; D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005838:Genotype; D019190:Iron Overload / Q000150:complications; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D011164:Porphyrias / Q000139:chemically induced* / Q000209:etiology / Q000235:genetics*; D018336:Receptors, Aryl Hydrocarbon / Q000235:genetics*; D013045:Species Specificity; D014575:Uroporphyrinogen Decarboxylase / Q000378:metabolism
chemical_list: D018336:Receptors, Aryl Hydrocarbon; D000622:Aminolevulinic Acid; D003577:Cytochrome P-450 Enzyme System; D014575:Uroporphyrinogen Decarboxylase